医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

DistilBio Enterprise, a Graph-based Data Discovery and Exploration Platform Launched for the Life Sciences

2013年09月25日 AM02:25
このエントリーをはてなブックマークに追加


 

SAN FRANCISCO & BANGALORE, India

Metaome Science Informatics, a bioinformatics start-up based in Bangalore, India today announced the launch of DistilBio Enterprise, a revolutionary knowledge discovery and exploration platform for the Life Sciences. Built for the enterprise, it combines novel graph-based search and analytics with advanced data integration technology that cuts across data silos.

DistilBio Enterprise seamlessly integrates data from instruments, internal knowledge bases, external data sources and enables the user to ask complex questions across the these sources. It is able to bring together both structured and unstructured data related to the life sciences such as genes, proteins, pathways, drugs, sequences, mutations, cell lines along with raw or processed data from laboratory instruments. DistilBio’s graph-based search technology enables users to discover hidden relationships buried deep within and across these data silos.

At the core of DistilBio Enterprise is a vast life sciences ontology that drives an intelligent data integration pipeline. The ontology also powers the graph-based querying technology that automatically recognizes gene names, pathways, diseases etc. and also all the relationships between them.

Speaking on the launch, Kalpana Krishnaswamy, chief executive officer, Metaome Science Informatics said, “The amount of data is exploding, and analyzing not only large but disparate data types will become a key differentiator for life sciences companies and provide much needed visibility in research & development. Metaome is at the forefront of providing breakthrough technologies for the life sciences sector and DistilBio Enterprise will democratize big data exploration and discovery in an unprecedented manner.”

“The use of big data analytics is exploding in the biotech and healthcare sectors with the ever-increasing volume and variety of data. DistilBio Enterprise comes to the rescue by offering a seamless data integration along with a graphical point and click querying system. It does away with the need for informatics support to access complex databases and as a result, puts the biologist directly in charge of asking the questions,” said Ramkumar Nandkumar, chief technology officer, Metaome Science Informatics.

DistilBio Enterprise is based on Metaome’s popular DistilBio Online which is available for free. The online version currently integrates more than thirty commonly referenced public domain Life Sciences databases covering more than thirty million biological entities such as genes, proteins, drugs, compounds, pathways and diseases.

Metaome’s DistilBio Enterprise technology finds applications in drug discovery, life sciences R&D, pharma R&D and Health care. Metaome is already in discussions with major pharma companies and research institutes to implement DistilBio Enterprise.

For more information, please visit http://distilbio.com/enterprise.

About Metaome

Metaome is a life science focussed informatics company based in Bangalore, India. Metaome delivers knowledge-mining solutions that are able to unlock competitive advantage, through its data integration and semantic search platform. Metaome was incubated at the Indian Institute of Management (IIM) Bangalore, India.

CONTACT

Metaome Science Informatics
Akhila Deshpande
+91 – 9886173819
akhila@metaome.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表